Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Medicare Expands Access for Weight Loss Drugs to Some Beneficiaries

Medicare has created a pathway for certain beneficiaries to access weight loss medications. This development follows a notable increase in the number of adults reporting GLP-1 drug usage for weight loss.

07/24/2026 · North Carolina edition

Advertisement

Advertisement

Why it matters locally: The expansion of Medicare access for weight loss drugs will directly affect a significant portion of North Carolina's senior population who rely on Medicare for their healthcare needs. This change could impact health outcomes and healthcare costs for thousands of beneficiaries across the state.

The utilization of GLP-1 medications for weight loss has shown an increase among American adults. A new Gallup poll indicates that 11% of adults currently use one of these drugs. This represents a significant rise from two years prior, when 3% of adults reported using them. Medicare has now made it possible for some patients to obtain these medications. William Brangham discussed these developments with Juliette Cubanski.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from North Carolina

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from North Carolina

health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Experimental Vaccine Shows Promise Against Glioblastoma

An experimental vaccine for glioblastoma, a severe form of brain cancer, demonstrates potential to prolong life for patients. Developers report encouraging results from ongoing studies.

Read Story →
health

Medicare for All Becomes Midterm Campaign Focus Amid Voter Support

Candidates in midterm elections are increasingly discussing 'Medicare for All.' A recent poll shows two-thirds of Americans support the concept. This reflects a public desire for significant changes in health care.

Read Story →
Scroll for more stories